Amgen | AMGN - Trade Creditors


Amgen reported $2.86B in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
ALKERMES USD 142.86M 40.5M Jun/2026
Amgen USD 2.86B 16.65B Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
Coherus Biosciences USD 13.17M 1.69M Jun/2026
Eli Lilly USD 6.11B 1.08B Jun/2026
Exelixis USD 24.15M 5.47M Mar/2026
Genmab DKK 6M 2M Sep/2025
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Glaxosmithkline GBP 14.34B 6.39B Mar/2026
Incyte USD 1.39B 1.16B Jun/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
J&J USD 9.22B 1.24B Jun/2026
Merck USD 3.86B 541M Mar/2026
Moderna USD 167M 6M Jun/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.58B 75M Jun/2026
PTC Therapeutics USD 40.45M 14.96M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.16B 132.2M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Takeda JPY 446.78B 44.56B Jun/2026
Teva Pharmaceutical Industries USD 2.72B 125M Jun/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026